https://www.selleckchem.com/pr....oducts/pf-9363-ctx-6
001 and = 0.015, respectively). The radiomics nomogram achieved good discriminant results in the training cohort ( -index 0.779) and the validation cohort ( -index 0.71 as well as good calibration. Decision curve analysis revealed that the proposed model significantly improved the clinical benefit compared with the clinical-based nomogram ( 0.001). This multicenter study demonstrates that a radiomics nomogram incorporated the radiomics signature and clinical-based risk factors can increase the predictive value of the oste
Like
Comment
Share
